T. Rowe Price launches Biotech active equity ETF on Nasdaq under TDNA
TROW•T. Rowe Price expands active ETF lineup with three new funds
T. Rowe Price launched three active equity ETFs on Nasdaq: TDNA, TSEE, and TMID, expanding its active ETF lineup to 38 funds.
- TDNA targets long-term capital growth in biotechnology; expected to hold 60-120 stocks; expense ratio 0.55%.
- TSEE provides diversified U.S. small-cap exposure; typically holds 200+ stocks; expense ratio 0.59%.
- TMID is an actively managed core U.S. mid-cap strategy; typically holds 300+ stocks; expense ratio 0.47%.
The launches bring the firm’s new active ETFs this year to eight, broadening coverage across equity segments.
